Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Chaitanya Iragavarapu"'
Publikováno v:
Clinical Case Reports, Vol 12, Iss 2, Pp n/a-n/a (2024)
Abstract Monoclonal gammopathy of uncertain significance associated acquired von Willebrand syndrome is a serious bleeding condition driven by immunological clearance of von Willebrand factor and has limited treatment options. We present a patient wh
Externí odkaz:
https://doaj.org/article/8e39608a34364d67bc6921c6c201cd61
Autor:
Christopher G. Burkeen, David Pottinger, Chaitanya Iragavarapu, Reshma Ramlal, Gerhard Hildebrandt
Publikováno v:
Case Reports in Hematology, Vol 2021 (2021)
Acute myeloid leukemia (AML) is the most common acute leukemia in American adults and portends a poor prognosis if untreated. Commonly, AML presents with symptoms related to concurrent leukopenia, anemia, or thrombocytopenia; however, due to its abil
Externí odkaz:
https://doaj.org/article/91aa13a08f3a49ec97971d7996941d24
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-7 (2018)
Abstract Recurrent gene mutations have been described with varying frequencies in myelodysplasia (MDS) /myeloproliferative neoplasm (MPN) overlap syndromes (MMOS). Recent work has placed significant focus on understanding the role of gene lesions inv
Externí odkaz:
https://doaj.org/article/397c70164c6b4e56af99100cebe76130
Publikováno v:
Biomarker Research, Vol 5, Iss 1, Pp 1-5 (2017)
Abstract Myelodysplasia (MDS) /myeloproliferative neoplasm (MPN) overlap syndrome has been described since the 2001 WHO classification as disorders that have both proliferative and dysplastic changes simultaneously. Specific disorders include chronic
Externí odkaz:
https://doaj.org/article/6c190a3244a348d2bc8275a6851cd63e
Autor:
Reshma Ramlal, Christopher G. Burkeen, Gerhard C. Hildebrandt, Chaitanya Iragavarapu, David Pottinger
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2021 (2021)
Case Reports in Hematology, Vol 2021 (2021)
Acute myeloid leukemia (AML) is the most common acute leukemia in American adults and portends a poor prognosis if untreated. Commonly, AML presents with symptoms related to concurrent leukopenia, anemia, or thrombocytopenia; however, due to its abil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e34fb40f15b7cf37dd0972e1bfec5f1e
https://doi.org/10.1155/2021/6621007
https://doi.org/10.1155/2021/6621007
Autor:
Lauren D. Curry, Reinhold Munker, Ning Li, Donglin Yan, Paul Pryor, Sahar Nozad, Patrick Keller, Gregory P. Monohan, Chaitanya Iragavarapu, Maxwell M. Krem
Publikováno v:
Annals of hematology.
Primary central nervous system lymphoma (PCNSL) occurs primarily in older patients and has a worse prognosis than other extranodal lymphomas. Contemporary treatment is based on high-dose methotrexate (HD-MTX), which crosses the blood-brain barrier. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c0206b6cc9875cb487811ddf7d5795
https://pubmed.ncbi.nlm.nih.gov/36367559
https://pubmed.ncbi.nlm.nih.gov/36367559
Publikováno v:
International Journal of Cancer Care and Delivery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fe0b0c50c00f2d3015c25cf0534059b
https://doi.org/10.53876/001c.33571
https://doi.org/10.53876/001c.33571
Autor:
Colby Canter, Gerhard Hildebrandt, Chaitanya Iragavarapu, Reinhold Munker, Ayman Qasrawi, Reshma Ramlal, Gregory Monohan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S250
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0c0e18ac6d337d0808c9255b8a63d0a
https://doi.org/10.1016/s2152-2650(22)01294-0
https://doi.org/10.1016/s2152-2650(22)01294-0
Autor:
Colby Canter, Gerhard Hildebrandt, Chaitanya Iragavarapu, Reinhold Munker, Ayman Qasrawi, Reshma Ramlal, Gregory Monohan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::823b852b000f090c10670af1f6bcc960
https://doi.org/10.1016/s2152-2650(22)00817-5
https://doi.org/10.1016/s2152-2650(22)00817-5
Publikováno v:
Expert opinion on biological therapy. 21(9)
Lisocabtagene Maraleucel (Liso-cel) is a second-generation Chimeric Antigen Receptor T-cell (CAR-T) therapy product targeting CD19. It is currently being evaluated for B-cell lymphomas with pivotal...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39726ec4bb21dd8bdb99a0739d76c1fd
https://pubmed.ncbi.nlm.nih.gov/34030548
https://pubmed.ncbi.nlm.nih.gov/34030548